Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Step Doses for Drug Provocation Tests to Prove Beta-lactam Hypersensitivity

NCT02839551 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT02839551
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02839551 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Step Doses for Drug Provocation Tests to Prove Beta-lactam Hypersensitivity
Lead sponsor
University Hospital, Montpellier
Phase
Not applicable
Overall status
Completed
Start date
May 4, 2016
Completion date
November 16, 2021
Enrollment
1,252 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug hypersensitivity